Huadong Medicine Co., Ltd (SHE:000963)
China flag China · Delayed Price · Currency is CNY
27.29
+0.34 (1.26%)
Oct 9, 2026, 3:04 PM CST

Huadong Medicine Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
47,85969,03160,55372,56582,08770,342
Market Cap Growth
-34.17%14.00%-16.55%-11.60%16.70%51.35%
Enterprise Value
44,81767,29858,71170,92381,58369,341
Last Close Price
27.2938.1132.7238.0142.5936.33

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
13.8020.2217.2425.5632.8530.56
Forward PE
15.1618.9819.8327.5730.3929.34
PS Ratio
1.091.581.451.792.182.04
PB Ratio
1.862.742.573.364.284.15
P/TBV Ratio
2.553.813.674.505.925.76
P/FCF Ratio
17.1925.8429.9631.2469.0629.92
P/OCF Ratio
11.1616.2616.1518.4734.4622.19
PEG Ratio
-1.621.331.490.600.60

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
EV/Sales Ratio
1.021.541.401.752.162.01
EV/EBITDA Ratio
8.8313.3411.5016.4321.6020.91
EV/EBIT Ratio
11.1916.3313.5319.7625.8624.71
EV/FCF Ratio
16.1025.1929.0530.5468.6429.50

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Debt / Equity Ratio
0.090.080.130.090.140.12
Debt / EBITDA Ratio
0.440.410.580.440.670.61
Debt / FCF Ratio
0.800.801.500.832.170.89
Net Debt / Equity Ratio
-0.13-0.12-0.09-0.13-0.07-0.11
Net Debt / EBITDA Ratio
-0.68-0.58-0.44-0.63-0.37-0.59
Net Debt / FCF Ratio
-1.22-1.10-1.11-1.17-1.19-0.83
Asset Turnover
1.121.131.171.261.301.35
Inventory Turnover
5.975.726.186.256.075.96
Quick Ratio
1.191.151.151.281.231.21
Current Ratio
1.611.621.531.711.731.67
Return on Equity (ROE)
13.82%14.00%15.48%13.97%14.02%14.56%
Return on Assets (ROA)
6.35%6.70%7.60%6.94%6.78%6.85%
Return on Invested Capital (ROIC)
14.59%16.07%17.55%16.10%16.09%16.02%
Return on Capital Employed (ROCE)
15.10%15.90%18.00%15.80%15.00%15.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Earnings Yield
7.23%4.95%5.80%3.91%3.04%3.27%
FCF Yield
5.82%3.87%3.34%3.20%1.45%3.34%
Dividend Yield
3.41%2.44%2.84%1.53%0.68%0.80%
Payout Ratio
48.43%49.56%48.47%20.93%23.07%19.99%
Buyback Yield / Dilution
0.50%-0.06%-0.08%-0.10%-0.00%0.00%
Total Shareholder Return
3.91%2.38%2.76%1.42%0.68%0.80%